Vilon

Vilon

โš ๏ธ Structural Separation Notice

The Ageless Pep Academy is a clinical education property independent from any commerce operation. Any references in this profile to Ageless Peps product SKUs, pricing, or the agelesspeps.com domain are for completeness and transparency; they are not endorsements and do not form part of the clinical education content. Clinicians are responsible for independent verification of any product sourcing decision. The Academy's Medical Director provides editorial oversight only and does not endorse commercial products.

Synthetic thymic dipeptide (Lys-Glu) bioregulator that modulates immune function via epigenetic chromatin remodeling and thymic support.

Methodological Note: >95% of published research on this peptide originates from the Khavinson bioregulation group (Institute of Bioregulation and Gerontology, St. Petersburg). Independent replication by Western laboratories is lacking. All evidence should be interpreted with this single-group limitation in mind.

Quick Facts

Property Value
Also Known As Violin (wholesale label), KE dipeptide, Lys-Glu
Category Immune / Anti-Aging / Khavinson Bioregulator
Sequence Lys-Glu (KE, 2 amino acids)
Molecular Weight ~275 Da
Molecular Formula C11H21N3O5
PubChem CID N/A โ€” research peptide not indexed
Administration SubQ
Typical Dose Range 10-20 mcg/day (from Khavinson protocols)
Half-Life Very short (minutes; typical of dipeptides)
Storage Lyophilized: -20C long-term; 2-8C short-term. Reconstituted: 2-8C for 2-4 weeks
FDA Status NOT FDA-approved. Approved in Russia as bioregulator; no Western regulatory approval
WADA Status Prohibited under S0 (non-approved substances)

Mechanism of Action

Vilon (Lys-Glu) is a synthetic dipeptide originally derived from Thymalin, a thymic extract preparation developed by Vladimir Khavinson's group at the St. Petersburg Institute of Bioregulation and Gerontology. It belongs to the class of ultrashort peptide bioregulators โ€” small peptides (2-4 amino acids) proposed to modulate gene expression by directly interacting with DNA and chromatin structures.

The primary proposed mechanism involves epigenetic regulation through chromatin remodeling. In cultured lymphocytes from elderly donors, Vilon induced reactivation (decondensation) of age-related heterochromatin, potentially making previously silenced genes accessible for transcription (PMID: 15105581). This chromatin decondensation effect is central to the Khavinson bioregulation theory.

Vilon is proposed to support thymic function and T-cell differentiation. In the broader Khavinson framework, thymus-derived short peptides act as endogenous regulators of immune homeostasis, and their depletion with age contributes to immunosenescence. Vilon is positioned as a synthetic replacement for these endogenous signaling peptides.

In animal studies, chronic Vilon administration inhibited spontaneous tumor growth and increased mean lifespan in SHR mice (PMID: 10944717), effects attributed to enhanced immune surveillance. Vilon also partially counteracted radiation-induced aging of the thymus and spleen in rats (PMID: 12096431).

Key Research Areas

  1. Immune senescence reversal โ€” Vilon's thymic support and T-cell differentiation promotion are the primary focus of Khavinson's research
  2. Chromatin remodeling โ€” Heterochromatin decondensation in aged cells is the proposed core mechanism
  3. Anti-tumor activity โ€” Inhibition of spontaneous tumors in mice, attributed to immune surveillance enhancement
  4. Geroprotection โ€” Lifespan extension in animal models through immune system restoration

Evidence Level Summary

Evidence Type Count Notes
Human RCTs 0 No randomized controlled trials
Human observational 0 No human clinical studies
Animal in vivo 2 Mouse lifespan/tumor study; rat thymus/spleen radiation model
In vitro 2 Chromatin reactivation in elderly lymphocytes; THP-1 cell line
Systematic reviews 1 Khavinson self-review of peptide gene regulation (2021)

Clinical Applications

  • Immune Support โ€” Proposed thymic restoration and T-cell support
  • Anti-Aging โ€” Chromatin remodeling and geroprotective effects in animal models

Protocols Using This Peptide

  • No established clinical protocols. Used in Khavinson bioregulation research protocols only.

Ageless Peps Products

  • APWS-Vilon-Vial โ€” Violin (Vilon) Vial, wholesale only

Dosing Reference

Research Dosing Ranges (from literature)

Route Dose Range Frequency Duration Source
SubQ 10-20 mcg Daily 10-20 days Khavinson protocols

Cycling

Khavinson protocols typically recommend 10-20 day treatment courses with 1-3 month intervals between courses. No independent validation of these cycling parameters exists.

Contraindications & Safety

  • Contraindications: Unknown โ€” no systematic safety studies in humans
  • Common side effects: Unknown โ€” no human clinical data
  • Drug interactions: Unknown โ€” no interaction studies conducted
  • Pregnancy/nursing: Contraindicated (no safety data)
  • Special populations: No data in any special population

Synergistic Combinations

Per Khavinson protocols (unvalidated):

Related Research

PMID Title Year Study Type
10944717 Vilon Inhibits Spontaneous Tumors and Increases Lifespan in Mice 2000 Animal in vivo
15105581 Vilon-Induced Chromatin Reactivation in Lymphocytes from Old People 2004 In vitro
27909961 Short Peptides Regulate Gene Expression 2016 Narrative Review
34834147 Peptide Regulation of Gene Expression: A Systematic Review 2021 Systematic Review
35408963 Peptides Regulating Proliferative Activity in THP-1 Cell Line 2022 In vitro

References

  • PMID 10944717 โ€” Vilon anti-tumor/lifespan study
  • PMID 15105581 โ€” Chromatin reactivation in aged lymphocytes
  • PMID 12096431 โ€” Radiation aging model
  • PMID 27909961 โ€” Short peptides regulate gene expression
  • PMID 34834147 โ€” Systematic review of peptide gene regulation

Related

#peptide #immune #anti-aging #khavinson-bioregulator #subq